Cargando…
Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation
Microtubule-associated serine/threonine kinase-like (MASTL) regulates mitotic progression and is an attractive target for the development of new anticancer drugs. In this study, novel inhibitory molecules were screened against MASTL kinase, a protein involved in cell proliferation in breast cancer....
Autores principales: | Polisety, Aneesha, Misra, Gauri, Rajawat, Jyotika, Katiyar, Amit, Singh, Harpreet, Bhatt, Anant Narayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124600/ https://www.ncbi.nlm.nih.gov/pubmed/35599277 http://dx.doi.org/10.1007/s12032-022-01701-3 |
Ejemplares similares
-
The Oncogenic Functions of MASTL Kinase
por: Marzec, Kamila, et al.
Publicado: (2018) -
Kinase-Independent Functions of MASTL in Cancer: A New Perspective on MASTL Targeting
por: Conway, James Ronald William, et al.
Publicado: (2020) -
SILAC kinase screen identifies potential MASTL substrates
por: Marzec, Kamila A., et al.
Publicado: (2022) -
Inhibition of Glycogen Synthase Kinase 3 (GSK3) Increases the Cytotoxicity of Enzastaurin
por: Rovedo, Mark, et al.
Publicado: (2011) -
Mastl kinase, a promising therapeutic target, promotes cancer recurrence
por: Wang, Ling, et al.
Publicado: (2014)